First, they showed that TP53 and/or RUNX1 mutations detected in sAML/sMDS, were already present in HSPCs at the time of transplantation (HCT was usually years before onset of sAML/sMDS). This evidence concerns the gene RUNX1 and spondylometaphyseal dysplasia, Sedaghatian type.